deuterated praziquantel analogs (Therapeutics for Rare and Neglected Diseases/CoNCERT Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedeuterated praziquantel analogs (Therapeutics for Rare and Neglected Diseases/CoNCERT Pharmaceuticals)
Drug Alias Namedeuterated praziquantel analogs (CoNCERT Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSchistosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesConcert Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesConcert Pharmaceuticals IncTherapeutics For Rare And Neglected Diseases (Trnd)
Active IndicationsN/A
Inactive IndicationsSchistosomiasis

Other Information

ATC CodeN/A
Related LinksN/A